Virtual Medicinal Product (VMP)
-
Ondansetron 16mg suppositories
Name Details
Current Name
Ondansetron 16mg suppositories
|
Start Date
12-03-2003
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- suppository
- Unit Dose UOM
- suppository
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Rectal
- Form
- Suppository
- Ontology Form/Route
- suppository.rectal
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
A04AA01
BNF |
Current BNF
04060000
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
04060000
|
Start Date
14-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
42038411000001101 |
07-07-2023 |
|
322184008 |
12-03-2003 |
06-07-2023 |
VMP Ingredients
VMP ingredients table
Ondansetron |
Based on Ingredient Substance |
|
16 mg |
|
Name
Ondansetron
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
16
Strength and UOM (Dmr)
Parent Products
-
VTM
Ondansetron
-
VMP
(Current) Ondansetron 16mg suppositories
Virtual Medicinal Product Pack (VMPP) Information